Lexaria Bioscience (NASDAQ:LEXX) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
Lexaria Bioscience Corp. (LEXX)
Company Research
Source: Yahoo! Finance
For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. Given this risk, we thought we'd take a look at whether Lexaria Bioscience NASDAQ:LEXX ) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Does Lexaria Bioscience Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at February 2026, Lexaria Bioscience had cash of US$5.3m and no deb
Show less
Read more
Impact Snapshot
Event Time:
LEXX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEXX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEXX alerts
High impacting Lexaria Bioscience Corp. news events
Weekly update
A roundup of the hottest topics
LEXX
News
- Lexaria Launches New Study to Examine Next-Generation GLP-1 DrugsACCESS Newswire
- Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales [Yahoo! Finance]Yahoo! Finance
- Lexaria's Robust Patent Portfolio Continues to Grow [Yahoo! Finance]Yahoo! Finance
- Lexaria Bioscience: Oral Drug Delivery Technology Targets Next-Gen Weight Loss Market [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Lexaria Bioscience: Improving Oral Weight-Loss Drug Tolerability [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
LEXX
Sec Filings
- 4/13/26 - Form 10-Q
- 3/18/26 - Form 4
- 2/6/26 - Form 8-K
- LEXX's page on the SEC website